Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69097-893

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69097-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Sevelamer Carbonate Tablets is a prescription medication manufactured by Cipla used to treat high levels of phosphorus in the blood, a condition called hyperphosphatemia, in people with chronic kidney disease on dialysis. Each film-coated tablet contains 800 mg of sevelamer carbonate in addition to some inactive ingredients. The usual dosage of the medication is provided in the package insert. The medication should be stored in a light-resistant container and protected from moisture within the range of 20°C to 25°C. The manufacturer of this medication is Cipla USA and it is manufactured by InvaGen Pharmaceuticals.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

This text does not provide enough detail to generate a useful description. It appears to be a chemical formula with some molecular groups listed, but without context or further information it is difficult to draw any conclusions or provide any specific meaning.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

This appears to be data from a clinical trial evaluating the efficacy of Sevelamer Hydrochloride in reducing serum phosphorus levels in patients with a specific condition. The graph shows the percentage of patients experiencing improvement or worsening of their condition after treatment with Sevelamer Hydrochloride compared to an active control. The reduction in serum phosphorus levels from baseline is also displayed. Further context or details cannot be inferred from the provided text.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.